TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman April 1, 1994
TCL Archive Dana-Farber Accepts Responsibility For Death Of One Patient, Harm To Another March 31, 1995